CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation

被引:42
|
作者
Saliba, Walid [1 ,2 ,3 ]
Rennert, Gad [1 ,2 ,4 ]
机构
[1] Technion Israel Inst Technol, Clalit Hlth Serv, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Haemek Med Ctr, IL-18101 Afula, Israel
[4] Clalit Hlth Serv Headquarters, Off Chief Phys, Dept Epidemiol & Dis Prevent, Tel Aviv, Israel
来源
AMERICAN JOURNAL OF MEDICINE | 2014年 / 127卷 / 01期
关键词
Atrial fibrillation; CHA(2)DS(2)-VASc; Mortality; Pulmonary embolism; DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; SERUM 25(OH)D; THROMBOEMBOLISM; STROKE; ATHEROSCLEROSIS; GUIDELINES; MANAGEMENT; POPULATION; MORTALITY;
D O I
10.1016/j.amjmed.2013.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The risk stratification score, which includes Congestive heart failure, Hypertension, Age >= 75 [doubled], Diabetes, Stroke [doubled]-Vascular disease, Age 65-74, and Sex category [female] (CHA(2)DS(2)-VASc), is used to predict stroke in atrial fibrillation. However, whether high CHA(2)DS(2)-VASc score carries a higher risk of pulmonary embolism remains unknown. We aimed to investigate the association between the severity of CHA(2)DS(2)-VASc score and the incidence of pulmonary embolism. METHODS: A total of 73,541 adults with atrial fibrillation diagnosed before January 1, 2012, and no history of pulmonary embolism, were retrospectively identified from the computerized database of the Clalit Health Services, which is the largest not-for-profit health maintenance organization in Israel. The CHA(2)DS(2)-VASc score was calculated for each subject at study entry. The cohort was followed for the first occurrence of pulmonary embolism until December 31, 2012 (70,210 person-years). RESULTS: Pulmonary embolism developed in 158 subjects, representing an incidence of 225.0 per 100,000 person-years. The incidence of pulmonary embolism increased with increasing CHA(2)DS(2)-VASc score (P <.001). On Cox proportional analysis, CHA(2)DS(2)-VASc score was significantly associated with pulmonary embolism (hazard ratio, 1.22; 95% confidence interval [CI], 1.13-1.32) for a 1-point increase in CHA(2)DS(2)VASc score. The results were similar after adjusting for anticoagulants and antiplatelet use (hazard ratio, 1.24; 95% CI, 1.14-1.34), and remained unchanged after further adjustment for active malignancy. The predictive values for pulmonary embolism were similar for CHA(2)DS(2)-VASc score and the classic risk stratification score which includes Congestive heart failure, Hypertension, Age > 75 years, Diabetes, and Stroke [doubled] (CHADS(2)); the areas under the receiver operating characteristic curves were 0.619 (95% CI, 0.579-0.660) and 0.616 (95% CI, 0.575-0.656), respectively. CONCLUSIONS: CHA(2)DS(2)-VASc score is directly associated with the incidence of pulmonary embolism in atrial fibrillation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [1] Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
    Huisman, Menno V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (14) : 1395 - 1397
  • [2] Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
    Jagadish, Pooja S.
    Kabra, Rajesh
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)
  • [3] Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
    Pooja S. Jagadish
    Rajesh Kabra
    Current Cardiology Reports, 2019, 21
  • [4] CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation
    Semczuk-Kaczmarek, Karolina
    Platek, Anna E.
    Rys, Anna
    Adamowicz, Jakub
    Legosz, Pawel
    Kotkowski, Marcin
    Dudzik-Plocica, Alicja
    Gorko, Dariusz
    Szymanski, Filip M.
    Filipiak, Krzysztof J.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (11): : 1451 - 1457
  • [5] CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation
    Harb, Serge C.
    Wang, Tom Kai Ming
    Nemer, David
    Wu, Yuping
    Cho, Leslie
    Menon, Venu
    Wazni, Osama
    Cremer, Paul C.
    Jaber, Wael
    OPEN HEART, 2021, 8 (02):
  • [6] Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation
    Chao, T. F.
    Lip, G. Y. H.
    Chen, S. A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 774 - 774
  • [7] Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score
    Kaplan, Rachel M.
    Koehler, Jodi
    Ziegler, Paul D.
    Sarkar, Shantanu
    Zweibel, Steven
    Passman, Rod S.
    CIRCULATION, 2019, 140 (20) : 1639 - 1646
  • [8] Stroke Risk Based on CHA2DS2-VASc Score in the Absence of Atrial Fibrillation
    Nayyar, Raj
    Sheth, Dwijesh
    Chhabra, Lovely
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 658 - 659
  • [9] Changes in CHA2DS2-VASc score and risk of ischemic stroke among patients with atrial fibrillation
    Tsiartas, Eirinaios
    Samaras, Athanasios
    Papazoglou, Andreas S.
    Kartas, Anastasios
    Moysidis, Dimitrios V.
    Gemousakakis, Eleftherios
    Kamzolas, Odysseas
    Bekiaridou, Alexandra
    Doundoulakis, Ioannis
    Tzikas, Apostolos
    Giannakoulas, George
    HEART AND VESSELS, 2023, 38 (10) : 1267 - 1276
  • [10] CHA2DS2-VASc score as a predictor of stroke severity in patients with atrial fibrillation
    Lopez-Hidalgo, Miguel
    Pinto-Longart, Luis
    Eblen-Zajjur, Antonio
    Regis, Euler
    Reina, Jose
    Poggioli, Ignacio
    Ramirez, Jose
    INVESTIGACION CLINICA, 2024, 65 (04): : 418 - 425